Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Monte Rosa Therapeutics Inc

GLUE
Current price
3.12 USD -0.01 USD (-0.32%)
Last closed 3.1 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 156 252 720 USD
Yield for 12 month -66.91 %
Week
Month
Year
GLUE
21.11.2021 - 28.11.2021

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops an orally bioavailable molecular glue degrader for GSPT1, a a translation termination factor for the treatment of Myc-driven cancers. It also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as gout and Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and a therapeutically-relevant protein in hemoglobinopathies. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210

Analytics

WallStreet Target Price

16.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -135 091 008 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -28.89 %
PEG Ratio
Return On Equity TTM -55.88 %
Wall Street Target Price 16.5 USD
Revenue TTM
Book Value 3.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.69 USD
Diluted Eps TTM -2.69 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GLUE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.1821
Price Book MRQ 0.8495

Financials GLUE

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GLUE

For 52 weeks

2.44 USD 9.72 USD
50 Day MA 3.8 USD
Shares Short Prior Month 3 347 452
200 Day MA 5.84 USD
Short Ratio 7.4
Shares Short 3 057 272
Short Percent 11.38 %